U.S. Securities & Exchange Commission
SEC Seal
Home | Search Home | Latest Filings | Previous Page
U.S. Securities and Exchange Commission


PASQUALONE FRANK (0001597334)
Mailing Address
901 GATEWAY BLVD
SOUTH SAN FRANCISCO CA 94080
Ownership Reports for Issuers: (Click on issuer name to see other owners for the issuer, or CIK for issuer filings.)

Issuer Filings Transaction Date Type of Owner
SPATIALIZER AUDIO LABORATORIES INC
Current Name:Enveric Biosciences, Inc.		 0000890821 2023-09-15 director
Theravance Biopharma, Inc. 0001583107 2014-05-14 officer: Sr. Vice President, Operations
Innoviva, Inc. 0001080014 2014-01-13 officer: Sr. Vice President, Operations


Items 1 - 40

The information presented below contains only portions of the information presented in the referenced filing or filings.
You should consult the original filing for complete information. Hyperlinks to the forms are provided for your convenience.

Acquistion or Disposition Transaction Date Deemed Execution Date Issuer Form Transaction Type Direct or Indirect Ownership Number of Securities Transacted Number of Securities Owned Line Number Issuer CIK Security Name
A 2024-10-09   Enveric Biosciences, Inc. 4 A-Award --D 47733.0000 48733.0000 1 0000890821 Common Stock
A 2023-09-15   Enveric Biosciences, Inc. 4 P-Purchase --D 1000.0000 1000.0000 1 0000890821 Common Stock
D 2021-11-19   Theravance Biopharma, Inc. 4 F-InKind --D 3779.0000 429783.0000 1 0001583107 Ordinary Shares
D 2021-08-20   Theravance Biopharma, Inc. 4 F-InKind --D 3779.0000 433562.0000 1 0001583107 Ordinary Shares
D 2021-05-20   Theravance Biopharma, Inc. 4 F-InKind --D 3779.0000 437341.0000 1 0001583107 Ordinary Shares
D 2021-02-20   Theravance Biopharma, Inc. 4 F-InKind --D 26961.0000 439719.0000 1 0001583107 Ordinary Shares
A 2021-02-08   Theravance Biopharma, Inc. 4 A-Award --D 65000.0000 466680.0000 1 0001583107 Ordinary Shares
D 2020-11-20   Theravance Biopharma, Inc. 4 F-InKind --D 4214.0000 401680.0000 1 0001583107 Ordinary Shares
D 2020-08-20   Theravance Biopharma, Inc. 4 F-InKind --D 4214.0000 405894.0000 1 0001583107 Ordinary Shares
D 2020-05-20   Theravance Biopharma, Inc. 4 F-InKind --D 4214.0000 410108.0000 1 0001583107 Ordinary Shares
D 2020-02-20   Theravance Biopharma, Inc. 4 F-InKind --D 24392.0000 412920.0000 1 0001583107 Ordinary Shares
A 2020-02-03   Theravance Biopharma, Inc. 4 A-Award --D 54000.0000 437312.0000 2 0001583107 Ordinary Shares
A 2020-02-03   Theravance Biopharma, Inc. 4 A-Award --D 65000.0000 383312.0000 1 0001583107 Ordinary Shares
D 2019-11-20   Theravance Biopharma, Inc. 4 F-InKind --D 2447.0000 318312.0000 1 0001583107 Ordinary Shares
D 2019-08-20   Theravance Biopharma, Inc. 4 F-InKind --D 2335.0000 320759.0000 1 0001583107 Ordinary Shares
D 2019-05-20   Theravance Biopharma, Inc. 4 F-InKind --D 1604.0000 323094.0000 1 0001583107 Ordinary Shares
D 2019-02-20   Theravance Biopharma, Inc. 4 F-InKind --D 4919.0000 323671.0000 1 0001583107 Ordinary Shares
A 2019-02-05   Theravance Biopharma, Inc. 4 A-Award --D 65000.0000 281340.0000 1 0001583107 Ordinary Shares
A 2019-02-05   Theravance Biopharma, Inc. 4 A-Award --D 47250.0000 328590.0000 2 0001583107 Ordinary Shares
D 2018-11-20   Theravance Biopharma, Inc. 4 F-InKind --D 5735.0000 216340.0000 1 0001583107 Ordinary Shares
D 2018-08-20   Theravance Biopharma, Inc. 4 F-InKind --D 5735.0000 222075.0000 1 0001583107 Ordinary Shares
D 2018-05-20   Theravance Biopharma, Inc. 4 F-InKind --D 18424.0000 227810.0000 1 0001583107 Ordinary Shares
A 2018-05-14   Theravance Biopharma, Inc. 4 A-Award --D 33750.0000 246234.0000 1 0001583107 Ordinary Shares
D 2018-02-20   Theravance Biopharma, Inc. 4 F-InKind --D 4741.0000 211619.0000 1 0001583107 Ordinary Shares
A 2018-02-12   Theravance Biopharma, Inc. 4 A-Award --D 9000.0000 216360.0000 1 0001583107 Ordinary Shares
D 2017-11-20   Theravance Biopharma, Inc. 4 F-InKind --D 5820.0000 207360.0000 1 0001583107 Ordinary Shares
A 2017-08-21   Theravance Biopharma, Inc. 4 P-Purchase --D 4000.0000 213180.0000 1 0001583107 Ordinary Shares
D 2017-08-20   Theravance Biopharma, Inc. 4 F-InKind --D 5820.0000 209180.0000 1 0001583107 Ordinary Shares
D 2017-05-20   Theravance Biopharma, Inc. 4 F-InKind --D 5820.0000 215000.0000 1 0001583107 Ordinary Shares
D 2017-02-20   Theravance Biopharma, Inc. 4 F-InKind --D 8762.0000 219118.0000 1 0001583107 Ordinary Shares
A 2017-02-06   Theravance Biopharma, Inc. 4 A-Award --D 9000.0000 227880.0000 1 0001583107 Ordinary Shares
A 2016-03-15   Theravance Biopharma, Inc. 4 A-Award --D 90000.0000 217178.0000 1 0001583107 Ordinary Shares
D 2016-02-20   Theravance Biopharma, Inc. 4 F-InKind --D 10830.0000 127178.0000 1 0001583107 Ordinary Shares
A 2015-02-05   Theravance Biopharma, Inc. 4 A-Award --D 130000.0000 135714.0000 1 0001583107 Ordinary Shares
A 2014-06-03   Theravance Biopharma, Inc. 4 A-Award --D 100000.0000 100000.0000 1 0001583107 Stock Option (Right to Buy)
A 2014-01-23   THERAVANCE INC 4 A-Award --D 20000.0000 20000.0000 1 0001080014 Common Stock
A 2014-01-23   THERAVANCE INC 4 A-Award --D 150000.0000 150000.0000 2 0001080014 Stock Option (Right to Buy)
- -   Enveric Biosciences, Inc. 3 - --- 1 - -
- -   Theravance Biopharma, Inc. 3 - --- 1 - -
- -   THERAVANCE INC 3 - --- 1 - -

http://www.sec.gov/cgi-bin/own-disp

Home | Search Home | Previous Page
Modified: 04/22/2016